Charles Canter, M.D.

Profile picture
Medical Director, Cardiac Transplant Program, St. Louis Children's Hospital
Researcher, Patient Oriented Research Unit
Patient Oriented Research UnitCardiology

phone: (314) 454-6095


  • BS, Brown University1974
  • MSc, Brown University1976
  • MD, Saint Louis University School of Medicine1979


  • Intern, St. Louis Children's Hospital, St. Louis, MO1979 - 1980
  • Assistant Resident, St. Louis Children's Hospital1980 - 1982
  • Resident-Fellow, St. Louis Children's Hospital1982 - 1984

Licensure and Board Certification

  • IL, Medical License
  • MO, Medical License
  • National Board of Medical Examiners 1980
  • American Board of Pediatrics 1984
  • APB, Sub-Board of Pediatric Cardiology, recertified 1995,recertified 2002,recertified 2015 1988


  • Fellowship, American Heart Association Seminar on Cardiovascular Epidemiology - Pres
  • Upjohn Achievement Award1979
  • Best Doctors in America2003
  • Medical Honoree, American Heart Association, Heartland Affiliate2004
  • New endowed professorship from St. Louis Children’s Hospital – The Lois B. Tuttle and Jeanne B. Hauck Chair in Pediatrics.2012 - Pres
  • Parkway School District Hall of Fame2016 - Pres

Recent Publications view all (194)

  1. Outcomes and Trends of Ventricular Assist Device Selection in Children with End-Stage Heart Failure. ASAIO J. 2017;4(464-469):464-469. PMID:28009713  
  2. The influence of race and common genetic variations on outcomes after pediatric heart transplantation. Am J Transplant 2017 17; 1525-39. Am J Transplant 2017. 2017;1525-1539. PMID:27931092 
  3. Pediatric and adult dilated cardiomyopathy represent distinct pathologic JCI Insight. 2017;14. PMID:28724792 
  4. Berlin Heart post approval outcomes in North America ASAIO J. 2017;63:193-197. PMID:28234657 
  5. The impact of age in the incidence and prevalence of moderate to severe cellular rejection detected by routine surveillance biopsy in pediatric heart transplantation J Heart Lung Transplant. 2017;36:451-456. PMID:27865735 
  6. Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis. J Card Fail. 2016;22(7):520-8. PMID:26941007 
  7. Improved survival after heart transplant for failed Fontan patients with preserved ventricular function. J Heart Lung Transplant. 2016;35(7):877-83. PMID:27068035 
  8. Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Pediatr Cardiol. 2016. PMID:27272694 
  9. High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis. Pediatr Cardiol. 2016;37(2):399-404. PMCID:PMC4775434  PMID:26499513 
  10. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant. 2016;35(1):1-23. PMID:26776864 
  11. Early Biventricular Assist Device Use in Children: A Single-Center Review of 31 Patients. ASAIO J. 2015;61(6):688-94. PMID:26186261 
  12. Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. J Card Fail. 2015;21(11):877-84. PMCID:PMC4630116  PMID:26164213 
  13. The influence of pulmonary resistance on the success of pediatric heart transplantation: Are there still boundaries? Pediatr Transplant. 2015;19(6):580-1. PMID:26215796 
  14. Continuous Flow Device Support in Children Using the HeartWare HVAD: 1,000 Days of Lessons Learned From a Single Center Experience. ASAIO J. 2015. doi:10.1097/MAT.0000000000000253  PMID:25967955 
  15. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation. 2015;131(18):1590-8. PMCID:PMC4573596  PMID:25940966 
  16. Pediatric Quality of Life while Supported with a Ventricular Assist Device. Congenit Heart Dis. 2015. doi:10.1111/chd.12260  PMID:25864509 
  17. Predicting graft loss by 1 year in pediatric heart transplantation candidates: an analysis of the Pediatric Heart Transplant Study database. Circulation. 2015;131(10):890-8. doi:10.1161/CIRCULATIONAHA.114.009120  PMID:25587099 
  18. Outpatient management of intra-corporeal left ventricular assist device system in children: a multi-center experience. Am J Transplant. 2015;15(2):453-60. doi:10.1111/ajt.13003  PMID:25612114 
  19. Successful bridge through transplantation with berlin heart ventricular assist device in a child with failing fontan. Ann Thorac Surg. 2015;99(2):707-9. doi:10.1016/j.athoracsur.2014.04.064  PMID:25639417 
  20. Intravenous home inotropic use is safe in pediatric patients awaiting transplantation. Circ Heart Fail. 2015;8(1):64-70. doi:10.1161/CIRCHEARTFAILURE.114.001528  PMID:25472966 
  21. Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2014;7(6):863-71. doi:10.1161/CIRCIMAGING.114.002411  PMCID:PMC4237712  PMID:25228707 
  22. B-type natriuretic peptide trends after pediatric heart transplantation. Pediatr Transplant. 2014. PMID:24922348 
  23. Echocardiographic normalization in children with idiopathic dilated cardiomyopathy: rsults from the Pediatric Cardiomyopathy Registry. J Am Coll cardiol. 2014;63:1405. 
  24. Liver cirrhosis in fontan patients does not affect one year post-heart transplant mortality or markers of liver function J Heart Lung Transplant. 2014;33:170. 
  25. Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure. Pediatr cardiol. 2014;35:411. 
  26. A Multicenter study of primary graft failure after infant heart transplantation: impact extracorporeal membrane oxygenation on outcomes. Pediatr transplant. 2014;18:72. 
  27. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol. 2014;63(14):1405-13. PMCID:PMC4030008  PMID:24561146 
  28. Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol. 2014;35(4):658-67. doi:10.1007/s00246-013-0835-9  PMID:24265000 
  29. Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure. Pediatr Cardiol. 2014;35(3):411-8. PMCID:PMC3944049  PMID:24061276 
  30. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33(2):170-7. PMCID:PMC3985609  PMID:24365764 
  31. Diagnosis and treatment of myocarditis in children in the current era. Circulation. 2014;129(1):115-28. PMID:24396015 
  32. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet. 2013;382(9908):1889-97. doi:10.1016/S0140-6736(13)61685-2  PMCID:PMC4007309  PMID:24011547 
  33. Heart transplantation in pediatric cardiomyopathies. Expert Rev Cardiovasc Ther. 2013;11(12):1677-90. PMID:24215197 
  34. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail. 2013;6(6):1214-22. PMCID:PMC4111626  PMID:24132734 
  35. Post-transplant outcomes of children bridged to transplant with the Berlin Heart EXCOR Pediatric ventricular assist device. Circulation. 2013;128(11 Suppl 1):S24-31. doi:10.1161/CIRCULATIONAHA.112.000446  PMID:24030413 
  36. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection. J Clin Apher. 2013;28(4):301-8. doi:10.1002/jca.21270  PMID:23426730 
  37. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation. 2013;127(16):1702-11. PMID:23538380 
  38. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart fail. 2013;6:1214. 
  39. Post-transplant outcomes of children bridged to transplant with the Berlin Heart Excor/Pediatric ventricular Device Circulation. 2013;128(S24):31. 
  40. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96. PMID:23245607 
  41. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223. PMID:23245608 
  42. Could contrast-enhanced cardiovascular MRI potentially be used to screen pediatric cardiac transplant patients for transplant coronary artery disease? Expert Rev Cardiovasc Ther. 2012;10(12):1459-61. doi:10.1586/erc.12.149  PMID:23253269 
  43. Noninvasive detection of transplant coronary artery disease with contrast-enhanced cardiac MRI in pediatric cardiac transplants. J Heart Lung Transplant. 2012;31(11):1234-5. doi:10.1016/j.healun.2012.06.001  PMID:22749830 
  44. Human polyomaviruses in children undergoing transplantation, United States, 2008-2010. Emerg Infect Dis. 2012;18(10):1676-9. doi:10.3201/eid1810.120359  PMCID:PMC3471627  PMID:23017293 
  45. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation. 2012;126(10):1237-44. doi:10.1161/CIRCULATIONAHA.112.104638  PMID:22843787 
  46. Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study. J Heart Lung Transplant. 2012;31(9):980-6. doi:10.1016/j.healun.2012.05.016  PMID:22884385 
  47. Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients. Ann Thorac Surg. 2012;94(3):807-15; discussion 815-6. doi:10.1016/j.athoracsur.2012.02.052  PMID:22632881 
  48. Renal function and genetic polymorphisms in pediatric heart transplant recipients. J Heart Lung Transplant. 2012;31(9):1003-8. doi:10.1016/j.healun.2012.05.010  PMCID:PMC3428223  PMID:22789135 
  49. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation. 2012;126(9):1079-86. doi:10.1161/CIRCULATIONAHA.110.011999  PMID:22800850 
  50. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367(6):532-41. doi:10.1056/NEJMoa1014164  PMID:22873533 
  51. The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr. 2012;25(8):842-854.e6. doi:10.1016/j.echo.2012.05.004  PMID:22677278 
  52. Early survival after heart transplant in young infants is lowest after failed single-ventricle palliation: a multi-institutional study. J Heart Lung Transplant. 2012;31(5):509-16. doi:10.1016/j.healun.2011.12.013  PMID:22325692 
  53. Failed Fontan heart transplant candidates with preserved vs impaired ventricular ejection: 2 distinct patient populations. J Heart Lung Transplant. 2012;31(5):545-7. doi:10.1016/j.healun.2012.02.003  PMID:22381208 
  54. A risk-prediction model for in-hospital mortality after heart transplantation in US children. Am J Transplant. 2012;12(5):1240-8. doi:10.1111/j.1600-6143.2011.03932.x  PMID:22300640 
  55. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012;31(4):398-409. doi:10.1016/j.healun.2011.11.019  PMCID:PMC3307902  PMID:22209354 
  56. Can adult heart failure regimens be applied to children: what works and what does not? Curr Opin Cardiol. 2012;27(2):98-107. PMID:22249216 
  57. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol. 2012;59(6):607-15. doi:10.1016/j.jacc.2011.10.878  PMCID:PMC3280885  PMID:22300696 
  58. Extracardiac complications of the Fontan circuit. Pediatr Radiol. 2012;42(2):233-41. doi:10.1007/s00247-011-2225-x  PMID:21863291 
  59. ABO-incompatible heart transplantation: analysis of the Pediatric Heart Transplant Study (PHTS) database. J Heart Lung Transplant. 2012;31(2):173-9. doi:10.1016/j.healun.2011.11.013  PMID:22305379 
  60. Spontaneous echocardiographic contrast associated with portosystemic shunt due to persistent patent ductus venosus. Congenit Heart Dis. 2012;7(3):E18-21. doi:10.1111/j.1747-0803.2011.00587.x  PMID:22129147 
  61. Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study. Pediatr Transplant. 2011;15(7):699-705. doi:10.1111/j.1399-3046.2011.01564.x  PMCID:PMC3201752  PMID:22004544 
  62. Outcomes after listing for primary transplantation for infants with unoperated-on non-hypoplastic left heart syndrome congenital heart disease: a multi-institutional study. J Heart Lung Transplant. 2011;30(9):1023-32. doi:10.1016/j.healun.2011.03.020  PMID:21550823 
  63. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation. 2011;124(7):814-23. doi:10.1161/CIRCULATIONAHA.110.973826  PMCID:PMC3199969  PMID:21788591 
  64. Preventing thrombosis after the Fontan procedure not there yet. J Am Coll Cardiol. 2011;58(6):652-3. PMID:21798430 
  65. Recent clinical and translational research on pediatric myocarditis. Prog Pediatr Cardiol. 2011;32(1):15-18. PMCID:PMC3649092  PMID:23667302 
  66. The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. J Heart Lung Transplant. 2011;30(7):755-60. doi:10.1016/j.healun.2011.01.718  PMCID:PMC3110638  PMID:21419658 
  67. Gene polymorphisms impact the risk of rejection with hemodynamic compromise: a multicenter study. Transplantation. 2011;91(12):1326-32. doi:10.1097/TP.0b013e31821c1e10  PMID:21659963 
  68. Acute myocarditis in children. Expert Rev Cardiovasc Ther. 2011;9(6):771-83. PMID:21714608 
  69. Impact of pulmonary vascular resistances in heart transplantation for congenital heart disease. Curr Cardiol Rev. 2011;7(2):59-66. PMCID:PMC3197090  PMID:22548028 
  70. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011;30(3):252-69. doi:10.1016/j.healun.2010.11.003  PMID:21300295 
  71. Infection and malignancy after pediatric heart transplantation: the role of induction therapy. J Heart Lung Transplant. 2011;30(3):299-308. doi:10.1016/j.healun.2010.09.005  PMID:21115369 
  72. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study. J Heart Lung Transplant. 2011;30(3):282-8. doi:10.1016/j.healun.2010.08.031  PMID:20974544 
  73. Outcomes of heart transplantation in young adults--more than a pediatric concern. J Heart Lung Transplant. 2011;30(2):139-40. PMID:21055969 
  74. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011;30(1):1-8. doi:10.1016/j.healun.2010.08.033  PMID:21145473 
  75. Association of genetic polymorphisms and risk of late post-transplantation infection in pediatric heart recipients. J Heart Lung Transplant. 2010;29(12):1342-51. doi:10.1016/j.healun.2010.07.013  PMID:20869265 
  76. Outcomes of pediatric heart transplant recipients transitioned to adult care: an exploratory study. J Heart Lung Transplant. 2010;29(11):1309-10. doi:10.1016/j.healun.2010.06.005  PMID:20619681 
  77. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010;29(11):1226-30. doi:10.1016/j.healun.2010.06.004  PMID:20691612 
  78. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010;3(6):689-97. doi:10.1161/CIRCHEARTFAILURE.109.902833  PMID:20833772 
  79. Dilated cardiomyopathy and heart failure in children. Heart Fail Clin. 2010;6(4):415-32, vii. PMID:20869643 
  80. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010;6(4):401-13, vii. PMCID:PMC2946942  PMID:20869642 
  81. Cardiomyopathies: Treating pediatric DCM--great expectations unfulfilled. Nat Rev Cardiol. 2010;7(8):420-2. doi:10.1038/nrcardio.2010.87  PMID:20657608 
  82. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-56. doi:10.1016/j.healun.2010.05.034  PMID:20643330 
  83. Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study. J Heart Lung Transplant. 2010;29(6):625-32. doi:10.1016/j.healun.2009.12.009  PMID:20207171 
  84. Current management of pediatric dilated cardiomyopathy. Curr Opin Cardiol. 2010;25(2):80-7. PMID:20019605 
  85. Tachyarrhythmias after pediatric heart transplantation. J Heart Lung Transplant. 2010;29(3):273-7. doi:10.1016/j.healun.2009.07.003  PMID:19783173 
  86. Distinct clinical and histopathological presentations of Danon cardiomyopathy in young women. J Am Coll Cardiol. 2010;55(4):408-10. doi:10.1016/j.jacc.2009.11.019  PMID:20117447 
  87. Socioeconomic status and pediatric heart transplantation--does it matter? J Heart Lung Transplant. 2009;28(12):1252-3. doi:10.1016/j.healun.2009.05.037  PMID:19782610 
  88. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail. 2009;2(6):591-8. doi:10.1161/CIRCHEARTFAILURE.108.839001  PMID:19919984 
  89. Quality of life in adult survivors greater than 10 years after pediatric heart transplantation. J Heart Lung Transplant. 2009;28(7):661-6. doi:10.1016/j.healun.2009.04.004  PMID:19560692 
  90. Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms. Transplantation. 2009;87(12):1801-6. doi:10.1097/TP.0b013e3181a755a4  PMCID:PMC2739874  PMID:19543056 
  91. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant. 2009;28(3):213-25. doi:10.1016/j.healun.2008.12.017  PMID:19285611 
  92. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch. J Heart Lung Transplant. 2008;27(10):1073-8. doi:10.1016/j.healun.2008.07.013  PMID:18926396 
  93. Biventricular assist devices as a bridge to heart transplantation in small children. Circulation. 2008;118(14 Suppl):S89-93. doi:10.1161/CIRCULATIONAHA.107.754002  PMID:18824776 
  94. Beyond Berlin: heart transplantation in the "untransplantable". J Thorac Cardiovasc Surg. 2008;136(2):529-31. doi:10.1016/j.jtcvs.2008.01.032  PMID:18692672 
  95. A fatal device-device interaction between a wearable automated defibrillator and a unipolar ventricular pacemaker. Pacing Clin Electrophysiol. 2008;31(7):912-5. doi:10.1111/j.1540-8159.2008.01110.x  PMID:18684292 
  96. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Transplantation. 2008;85(11):1632-9. doi:10.1097/TP.0b013e3181722edc  PMID:18551071 
  97. Infectious, malignant, and autoimmune complications in pediatric heart transplant recipients. J Pediatr. 2008;152(5):671-7. doi:10.1016/j.jpeds.2007.10.018  PMID:18410772 
  98. Pediatric heart failure therapy with beta-adrenoceptor antagonists. Paediatr Drugs. 2008;10(2):125-34. PMID:18345722 
  99. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298(10):1171-9. doi:10.1001/jama.298.10.1171  PMID:17848651 
  100. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant. 2007;26(9):876-82. doi:10.1016/j.healun.2007.07.011  PMID:17845925 
  101. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients. Pediatr Transplant. 2007;11(5):524-9. doi:10.1111/j.1399-3046.2007.00712.x  PMID:17631021 
  102. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome? J Heart Lung Transplant. 2007;26(5):447-52. doi:10.1016/j.healun.2007.02.005  PMID:17449412 
  103. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;115(5):658-76. PMID:17261651 
  104. Infant heart transplantation ten years later--where are they now? Ann Thorac Surg. 2007;83(1):169-71; discussion 172. doi:10.1016/j.athoracsur.2006.08.016  PMID:17184654 
  105. Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation. 2006;82(12):1774-80. doi:10.1097/  PMID:17198275 
  106. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867-76. doi:10.1001/jama.296.15.1867  PMID:17047217 
  107. Surveillance for transplant coronary artery disease in infant, child and adolescent heart transplant recipients: an intravascular ultrasound study. J Heart Lung Transplant. 2006;25(8):921-7. doi:10.1016/j.healun.2006.03.022  PMID:16890112 
  108. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114(4):273-80. doi:10.1161/CIRCULATIONAHA.105.548016  PMID:16847155 
  109. Lessons learned from the pediatric heart transplant study. Congenit Heart Dis. 2006;1(3):54-62. PMID:18377548 
  110. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients. Int J Pediatr Otorhinolaryngol. 2006;70(2):303-10. doi:10.1016/j.ijporl.2005.07.011  PMID:16125255 
  111. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006;367(9506):233-9. doi:10.1016/S0140-6736(06)67933-6  PMID:16427492 
  112. Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol. 2006;27(3):336-42. doi:10.1007/s00246-005-1159-1  PMID:16596434 
  113. Therapy for pediatric myocarditis. Curr Treat Options Cardiovasc Med. 2005;7(5):411-7. PMID:16138960 
  114. Relation of age, severity of illness, and hemodynamics with brain natriuretic peptide levels in patients <20 years of age with heart disease. Am J Cardiol. 2005;96(6):847-50. doi:10.1016/j.amjcard.2005.05.034  PMID:16169375 
  115. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant. 2005;24(6):645-51. doi:10.1016/j.healun.2004.03.021  PMID:15949722 
  116. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant. 2005;24(5):576-82. doi:10.1016/j.healun.2004.01.019  PMID:15896755 
  117. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. J Heart Lung Transplant. 2004;23(9):1040-5. doi:10.1016/j.healun.2003.08.014  PMID:15454169 
  118. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004;44(2):391-7. doi:10.1016/j.jacc.2004.04.035  PMID:15261937 
  119. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. J Heart Lung Transplant. 2004;23(6):716-22. PMID:15366432 
  120. Non-ischemic left ventricular dysfunction after pediatric cardiac transplantation: treatment with plasmapheresis and OKT3. J Heart Lung Transplant. 2004;23(5):552-7. doi:10.1016/S1053-2498(03)00308-5  PMID:15135370 
  121. Multi-detector row computed tomographic angiography in pediatric heart transplant recipients: Initial observations. Transplantation. 2004;77(4):599-602. PMID:15084942 
  122. Morbidities in patients with hypoplastic left heart syndrome. Pediatr Cardiol. 2004;25(1):3-10. doi:10.1007/s00246-003-0471-x  PMID:14534760 
  123. Whole blood international normalization ratio measurements in children using near-patient monitors. J Pediatr Hematol Oncol. 2003;25(1):33-7. PMID:12544771 
  124. Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome. J Heart Lung Transplant. 2002;21(4):455-9. PMID:11927222 
  125. Rejection is reduced in thoracic organ recipients when transplanted in the first year of life. J Heart Lung Transplant. 2002;21(3):311-8. PMID:11897518 
  126. Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure? Paediatr Drugs. 2002;4(12):771-8. PMID:12431129 
  127. A comparison of treatment strategies for hypoplastic left heart syndrome using decision analysis. J Am Coll Cardiol. 2001;38(4):1181-7. PMID:11583901 
  128. Long-term prostacyclin infusion to reduce pulmonary hypertension in a pediatric cardiac transplant candidate prior to transplantation. J Heart Lung Transplant. 2001;20(7):785-8. PMID:11448812 
  129. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001;138(4):505-11. doi:10.1067/mpd.2001.113045  PMID:11295713 
  130. Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study. J Heart Lung Transplant. 2001;20(3):279-87. PMID:11257553 
  131. Outcome after diagnosis of moderate-severe transplant coronary artery disease (TCAD) in pediatric heart transplant recipients. J Heart Lung Transplant. 2001;20(2):261-262. PMID:11250529 
  132. Death after cardiac transplantation in low birth weight neonates. J Heart Lung Transplant. 2001;20(2):260-261. PMID:11250526 
  133. Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior. J Pediatr Hematol Oncol. 2001;23(1):14-8. PMID:11196263 
  134. Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome. J Am Coll Cardiol. 2000;36(4):1178-85. PMID:11028468 
  135. Preoperative assessment and management of pediatric heart transplantation. Prog Pediatr Cardiol. 2000;11(2):91-97. PMID:10856690 
  136. Defective insulin receptors in Rabson-Mendenhall syndrome cause complete peripheral insulin resistance but minimal hepatic insulin response remains. Pediatr Diabetes. 2000;1(2):66-73. doi:10.1034/j.1399-5448.2000.010203.x  PMID:15016231 
  137. Increased morbidity and high variability of cyclosporine levels in pediatric heart transplant recipients. J Heart Lung Transplant. 2000;19(4):343-9. PMID:10775814 
  138. Transplant coronary artery disease in pediatric heart transplant recipients. J Heart Lung Transplant. 2000;19(3):240-8. PMID:10713248 
  139. Selective coronary angiography in pediatric patients. Pediatr Cardiol. 2000;21(3):285-8. doi:10.1007/s002460010064  PMID:10818198 
  140. Rejection with heart failure after pediatric cardiac transplantation. Ann Thorac Surg. 1999;68(1):176-80. PMID:10421137 
  141. Scimitar syndrome presenting in infancy. Ann Thorac Surg. 1999;67(1):154-9; discussion 160. PMID:10086541 
  142. Patterns and potential value of cardiac troponin I elevations after pediatric cardiac operations. Ann Thorac Surg. 1998;65(5):1394-9. PMID:9594873 
  143. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group. J Heart Lung Transplant. 1997;16(12):1255-66. PMID:9436138 
  144. Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Cardiol. 1997;30(2):554-60. PMID:9247532 
  145. Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study. Circulation. 1997;96(1):227-31. PMID:9236438 
  146. Cardiac troponin I in pediatrics: normal values and potential use in the assessment of cardiac injury. J Pediatr. 1997;130(6):872-7. PMID:9202607 
  147. Pediatric lung transplantation at St. Louis Children's Hospital, 1990-1995. Am J Respir Crit Care Med. 1997;155(3):1027-35. doi:10.1164/ajrccm.155.3.9116982  PMID:9116982 
  148. Infant and donor organ growth after heart transplantation in neonates with hypoplastic left heart syndrome. J Heart Lung Transplant. 1996;15(11):1093-100. PMID:8956118 
  149. Embolic stroke after ligation of the pulmonary artery in patients with functional single ventricle. Am Heart J. 1996;132(4):836-40. PMID:8831374 
  150. Lung transplantation in infancy and early childhood. J Heart Lung Transplant. 1996;15(9):895-902. PMID:8889985 
  151. Recognition and management of nonpenetrating cardiac trauma in children. J Pediatr. 1996;128(4):536-41. PMID:8618189 
  152. Echocardiographic characteristics of biopsy-proven cellular rejection in infant heart transplant recipients. J Heart Lung Transplant. 1996;15(1 Pt 1):25-34. PMID:8820080 
  153. Lung transplantation for congenital pulmonary vein stenosis. Ann Thorac Surg. 1995;60(4):903-6; discussion 907. PMID:7574992 
  154. Lung transplantation in children and young adults with cardiovascular disease. Ann Thorac Surg. 1995;59(4):813-20; discussion 820-1. PMID:7695402 
  155. Utility of surveillance biopsies in infant heart transplant recipients. J Heart Lung Transplant. 1995;14(6 Pt 1):1095-101. PMID:8719456 
  156. Elevated donor cardiac troponin I. A marker of acute graft failure in infant heart recipients. Circulation. 1994;90(6):2618-21. PMID:7994800 
  157. Predictors of operative mortality and morbidity after infant heart transplantation. Ann Thorac Surg. 1994;58(4):972-7. PMID:7944818 
  158. Neurologic complications of pediatric heart transplantation. Arch Pediatr Adolesc Med. 1994;148(9):973-9. PMID:8075745 
  159. Comparison of ventricular mass and function in early versus late repair of coarctation of the aorta. Am J Cardiol. 1994;73(9):698-701. PMID:8166068 
  160. Pediatric lung transplantation. Indications, techniques, and early results. J Thorac Cardiovasc Surg. 1994;107(4):990-9; discussion 999-1000. PMID:8159051 
  161. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression. J Heart Lung Transplant. 1994;13(1 Pt 1):74-9; discussion 79-80. PMID:8167131 
  162. Restrictive atrial septal communication as a determinant of outcome of cardiac transplantation for hypoplastic left heart syndrome. Circulation. 1993;88(5 Pt 2):II456-60. PMID:8222194 
  163. Early results after pediatric cardiac transplantation with triple immunosuppression therapy. Am J Cardiol. 1993;71(11):971-5. PMID:8465791 
  164. Endarteritis associated with a clinically silent patent ductus arteriosus. Am Heart J. 1993;125(4):1192-3. PMID:8465758 
  165. Technique of transplantation for hypoplastic left heart syndrome with left superior vena cava. Ann Thorac Surg. 1993;55(3):779-81. PMID:8452453 
  166. Repair of coarctation of the aorta in infancy: comparison of surgical and balloon angioplasty. Am Heart J. 1993;125(2 Pt 1):464-8. PMID:8427142 
  167. Damus-Kaye-Stansel with cavopulmonary connection for single ventricle and subaortic obstruction. Ann Thorac Surg. 1993;55(2):339-45; discussion 346. PMID:8431038 
  168. Pediatric endomyocardial biopsy performed solely with echocardiographic guidance. J Am Soc Echocardiogr. 1993;6(5):510-5. PMID:8260169 
  169. Pediatric lung transplantation for pulmonary hypertension and congenital heart disease. Ann Thorac Surg. 1992;54(2):216-23; discussion 224-5. PMID:1637208 
  170. Increased stiffness and persistent narrowing of the aorta after successful repair of coarctation of the aorta: relationship to left ventricular mass and blood pressure at rest and with exercise. Am Heart J. 1992;123(6):1594-600. PMID:1595541 
  171. Extracorporeal life support in cyanotic congenital heart disease before cardiovascular operation. Am J Cardiol. 1992;69(8):790-3. PMID:1546655 
  172. Primary surgical closure of large ventricular septal defects in small infants. Ann Thorac Surg. 1992;53(3):397-401. PMID:1540054 
  173. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression. Circulation. 1991;84(5 Suppl):III303-9. PMID:1657452 
  174. Surveillance for rejection by echocardiographically guided endomyocardial biopsy in the infant heart transplant recipient. Circulation. 1991;84(5 Suppl):III310-5. PMID:1934425 
  175. Evaluation of congenital heart disease by three-dimensional magnetic resonance imaging. J Digit Imaging. 1991;4(3):153-8. PMID:1911973 
  176. Noninvasive diagnosis of right-sided extracardiac conduit obstruction by combined magnetic resonance imaging and continuous-wave Doppler echocardiography. J Thorac Cardiovasc Surg. 1991;101(4):724-31. PMID:2008111 
  177. Antemortem diagnosis of gross cardiac metastasis in childhood leukemia: echocardiographic demonstration. Pediatr Cardiol. 1990;11(4):225-6. doi:10.1007/BF02238374  PMID:2148821 
  178. Rejection and infection with triple drug immunosuppression after pediatric cardiac transplantation Ann Thorac Surg . 1990;49:385. 
  179. Intraoperative evaluation of atrioventricular septal defect repair by color flow mapping echocardiography. Ann Thorac Surg. 1989;48(4):544-50. PMID:2802855 
  180. Magnetic resonance imaging in the evaluation of tetralogy of fallot Radiology. 1989;171:207. 
  181. Cardiac cycle dependent variation of integrated backscutter is not influenced by abnormal myocardial wall motion in human subjects with paradoxical septal motion Ultrasound Med Biol . 1989;15:311. 
  182. Extracorporeal membrane oxygenation (ECMO) for circulatory support after repair of congenital heart defects Ann Thor Surg . 1989;48:206. 
  183. Three- dimensional magnetic resonance imaging of the heart Radiol Technol . 1989;60:305. 
  184. Management and follow up of arterial thrombosis in the neonatal period J Peds. 1989;114:853. 
  185. Evaluation of pulmonary arterial morphology in cyanotic congenital heart disease by magnetic resonance imaging 1989;118:347. 
  186. Diagnosis of anomalous left coronary artery from the pulmonary trunk by color Doppler echocardiography Am Heart J. 1988;116(885). 
  187. Three dimensional MR imaging of congenital heart disease Radiographics. 1988;8:857. 
  188. Scimitar syndrome in childhood Am J Cardiol . 1986;58:652. 
  189. Atypical Kawasaki disease with aortic aneurysm Pediatrics. 1981;68:885. 
  190. Induction of extra nephron in unilateral nephrectomized immature rats Proc Soc Exp Biol Med. 1975;148:294. 
  191. Differences in presentation and outcomes between children with familial dilated cardiomyopathy and children with idiopathic dilated cardiomyopathy: A report from the Pediatric Cardiomyopathy Registry Study Group Circ Heart Failure. 
  192. A novel surgical approach to mechanical circulatory support in univentricular infants Ann Thorac Surg. 
  193. Berlin Heart EXCOR use in patients with congenital heart disease J Heart Lung Transplant. 
  194. The burden of early phenotypes and the impact of left ventricular wall thickness on hypertrophic cardiomyopathy sarcomere mutation carriers: finding from the HCMNet study. JAMA Cardiol. 
Last updated: 10/05/2017
© 2018 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130